NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO) valuation after fresh Wall Street upgrades and Asia bioprocessing expansion
Thermo Fisher Scientific (TMO) has been back in the spotlight after a wave of upbeat coverage from major banks, tying its stock story to improving life sciences demand and fresh bioprocessing expansion across Asia.
See our latest analysis for Thermo Fisher Scientific.
Those Asia bioprocessing moves and the new cardiac risk test partnership have arrived just as sentiment is turning, with Thermo Fisher’s share price up 16.8 percent over 90 days and its 1 year total shareholder return at 7.8...